Assessing the relationship between multimorbidity, NCD configurations, frailty phenotypes, and mortality risk in older adults.
Clusters
Frailty
Mortality
Multimorbidity
Older adults
Patterns
Journal
BMC geriatrics
ISSN: 1471-2318
Titre abrégé: BMC Geriatr
Pays: England
ID NLM: 100968548
Informations de publication
Date de publication:
22 Apr 2024
22 Apr 2024
Historique:
received:
14
08
2023
accepted:
04
04
2024
medline:
23
4
2024
pubmed:
23
4
2024
entrez:
22
4
2024
Statut:
epublish
Résumé
Older adults are increasingly susceptible to prolonged illness, multiple chronic diseases, and disabilities, which can lead to the coexistence of multimorbidity and frailty. Multimorbidity may result in various noncommunicable disease (NCD) patterns or configurations that could be associated with frailty and death. Mortality risk may vary depending on the presence of specific chronic diseases configurations or frailty. The aim was to examine the impact of NCD configurations on mortality risk among older adults with distinct frailty phenotypes. The population was analyzed from the Costa Rican Longevity and Healthy Aging Study Cohort (CRELES). A total of 2,662 adults aged 60 or older were included and followed for 5 years. Exploratory factor analysis and various clustering techniques were utilized to identify NCD configurations. The frequency of NCD accumulation was also assessed for a multimorbidity definition. Frailty phenotypes were set according to Fried et al. criteria. Kaplan‒Meier survival analyses, mortality rates, and Cox proportional hazards models were estimated. Four different types of patterns were identified: 'Neuro-psychiatric', 'Metabolic', 'Cardiovascular', and 'Mixt' configurations. These configurations showed a higher mortality risk than the mere accumulation of NCDs [Cardiovascular HR:1.65 (1.07-2.57); 'Mixt' HR:1.49 (1.00-2.22); ≥3 NCDs HR:1.31 (1.09-1.58)]. Frailty exhibited a high and constant mortality risk, irrespective of the presence of any NCD configuration or multimorbidity definition. However, HRs decreased and lost statistical significance when phenotypes were considered in the Cox models [frailty + 'Cardiovascular' HR:1.56 (1.00-2.42); frailty + 'Mixt':1.42 (0.95-2.11); and frailty + ≥ 3 NCDs HR:1.23 (1.02-1.49)]. Frailty accompanying multimorbidity emerges as a more crucial indicator of mortality risk than multimorbidity alone. Therefore, studying NCD configurations is worthwhile as they may offer improved risk profiles for mortality as alternatives to straightforward counts.
Sections du résumé
BACKGROUND
BACKGROUND
Older adults are increasingly susceptible to prolonged illness, multiple chronic diseases, and disabilities, which can lead to the coexistence of multimorbidity and frailty. Multimorbidity may result in various noncommunicable disease (NCD) patterns or configurations that could be associated with frailty and death. Mortality risk may vary depending on the presence of specific chronic diseases configurations or frailty.
METHODS
METHODS
The aim was to examine the impact of NCD configurations on mortality risk among older adults with distinct frailty phenotypes. The population was analyzed from the Costa Rican Longevity and Healthy Aging Study Cohort (CRELES). A total of 2,662 adults aged 60 or older were included and followed for 5 years. Exploratory factor analysis and various clustering techniques were utilized to identify NCD configurations. The frequency of NCD accumulation was also assessed for a multimorbidity definition. Frailty phenotypes were set according to Fried et al. criteria. Kaplan‒Meier survival analyses, mortality rates, and Cox proportional hazards models were estimated.
RESULTS
RESULTS
Four different types of patterns were identified: 'Neuro-psychiatric', 'Metabolic', 'Cardiovascular', and 'Mixt' configurations. These configurations showed a higher mortality risk than the mere accumulation of NCDs [Cardiovascular HR:1.65 (1.07-2.57); 'Mixt' HR:1.49 (1.00-2.22); ≥3 NCDs HR:1.31 (1.09-1.58)]. Frailty exhibited a high and constant mortality risk, irrespective of the presence of any NCD configuration or multimorbidity definition. However, HRs decreased and lost statistical significance when phenotypes were considered in the Cox models [frailty + 'Cardiovascular' HR:1.56 (1.00-2.42); frailty + 'Mixt':1.42 (0.95-2.11); and frailty + ≥ 3 NCDs HR:1.23 (1.02-1.49)].
CONCLUSIONS
CONCLUSIONS
Frailty accompanying multimorbidity emerges as a more crucial indicator of mortality risk than multimorbidity alone. Therefore, studying NCD configurations is worthwhile as they may offer improved risk profiles for mortality as alternatives to straightforward counts.
Identifiants
pubmed: 38649809
doi: 10.1186/s12877-024-04948-9
pii: 10.1186/s12877-024-04948-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
355Informations de copyright
© 2024. The Author(s).
Références
Hogan DB. Models, definitions, and criteria for frailty. In: Ram JL, Conn PM, editors. Conn’s handbook of models for human aging. Academic; 2018. pp. 35–44.
Brivio P, Paladini MS, Racagni G, Riva MA, Calabrese F, Molteni R. From healthy aging to frailty: in search of the underlying mechanisms. Curr Med Chem. 2019;26(20):3685–701.
doi: 10.2174/0929867326666190717152739
pubmed: 31333079
Xia S, Zhang X, Zheng S, Khanabdali R, Kalionis B, Wu J et al. An update on inflamm-aging: mechanisms, prevention, and treatment. J Immunol Res. 2016;2016.
Dodig S, Čepelak I, Pavić I. Hallmarks of senescence and aging. Biochem Med (Zagreb). 2019;29(3).
Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159(4):709–13.
doi: 10.1016/j.cell.2014.10.039
pubmed: 25417146
pmcid: 4852871
Makovski TT, Schmitz S, Zeegers MP, Stranges S, van den Akker M. Multimorbidity and quality of life: systematic literature review and meta-analysis. Ageing Res Rev. 2019;53:100903.
doi: 10.1016/j.arr.2019.04.005
pubmed: 31048032
Bloom DE, Boersch-Supan A, Mcgee P, Seike A. Population aging: facts, challenges, and responses. cdn1.sph.harvard.edu. 2011.
Wleklik M, Uchmanowicz I, Jankowska EA, Vitale C, Lisiak M, Drozd M, et al. Multidimensional approach to frailty. Front Psychol. 2020;11:517603.
doi: 10.3389/fpsyg.2020.00564
De Biasio JC, Mittel AM, Mueller AL, Ferrante LE, Kim DH, Shaefi S. Frailty in critical care medicine: a review. Anesth Analg. 2020 [cited 2023 Feb 8];130(6):1462. /pmc/articles/PMC7426653/
Ferrucci L, Gonzalez-Freire M, Fabbri E, Simonsick E, Tanaka T, Moore Z et al. Measuring biological aging in humans: a quest. Aging Cell. 2020;19(2).
Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ et al. Multimorbidity. Nat Rev Dis Primers. 2022 [cited 2022 Sep 15];8(1):1–22. https://www.nature.com/articles/s41572-022-00376-4
Le Reste JY, Nabbe P, Manceau B, Lygidakis C, Doerr C, Lingner H, et al. The European general practice research network presents a comprehensive definition of multimorbidity in family medicine and long term care, following a systematic review of relevant literature. J Am Med Dir Assoc. 2013;14(5):319–25.
doi: 10.1016/j.jamda.2013.01.001
pubmed: 23411065
Prados-Torres A, Calderón-Larrañaga A, Hancco-Saavedra J, Poblador-Plou B, Van Den Akker M. Multimorbidity patterns: a systematic review. J Clin Epidemiol. 2014;67(3):254–66.
doi: 10.1016/j.jclinepi.2013.09.021
pubmed: 24472295
Johnston MC, Crilly M, Black C, Prescott GJ, Mercer SW. Defining and measuring multimorbidity: a systematic review of systematic reviews. Eur J Public Health. 2019 [cited 2022 Oct 5];29(1):182–9. https://academic.oup.com/eurpub/article/29/1/182/5033670
The Academy of Medical Sciences. Multimorbidity: a priority for global health research. 2018. https://acmedsci.ac.uk/policy/policy-projects/multimorbidity
Whitty CJM, Watt FM. Map clusters of diseases to tackle multimorbidity. Nature. 2020 [cited 2023 Dec 18];579(7800):494–6. https://pubmed.ncbi.nlm.nih.gov/32210388/
Chowdhury SR, Chandra Das D, Sunna TC, Beyene J, Hossain A. Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis. EClinicalMedicine. 2023;57.
World Health Organization. Noncommunicable diseases country profiles 2018. 2018.
Bennett JE, Stevens GA, Mathers CD, Bonita R, Rehm J, Kruk ME, et al. NCD countdown 2030: worldwide trends in non-communicable disease mortality and progress towards sustainable development goal target 3.4. Lancet. 2018;392(10152):1072–88.
doi: 10.1016/S0140-6736(18)31992-5
Kanesarajah J, Waller M, Whitty JA, Mishra GD. Multimorbidity and quality of life at mid-life: a systematic review of general population studies. Maturitas. 2018;109:53–62.
doi: 10.1016/j.maturitas.2017.12.004
pubmed: 29452782
Sum G, Salisbury C, Koh GCH, Atun R, Oldenburg B, Mcpake B et al. Implications of multimorbidity patterns on health care utilisation and quality of life in middle-income countries: cross-sectional analysis. J Glob Health. 2019;9(2).
Ferrer A, Formiga F, Sanz H, Almeda J, Padrós G. Multimorbidity as specific disease combinations, an important predictor factor for mortality in octogenarians: the Octabaix study. Clin Interv Aging. 2017;12:223.
doi: 10.2147/CIA.S123173
pubmed: 28184153
pmcid: 5291453
Kadambi S, Abdallah M, Loh KP. Multimorbidity, function and cognition in aging. Clin Geriatr Med. 2020;36(4):569.
doi: 10.1016/j.cger.2020.06.002
pubmed: 33010895
pmcid: 8012012
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. Lancet. 2013;381(9868):752–62.
doi: 10.1016/S0140-6736(12)62167-9
pubmed: 23395245
Thillainadesan J, Scott IA, Le Couteur DG. Frailty, a multisystem ageing syndrome. Age Ageing. 2020 [cited 2023 Dec 20];49(5):758–63. https://doi.org/10.1093/ageing/afaa112
Rodríguez-Laso Á, Caballero Mora MÁ, García Sánchez I, Alonso Bouzón C, Rodríguez Mañas L, Bernabei R, et al. Updated state of the art report on the prevention and management of frailty. European Union; 2019.
O’Caoimh R, Sezgin D, O’Donovan MR, William Molloy D, Clegg A, Rockwood K, et al. Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies. Age Ageing. 2021;50(1):96–104.
doi: 10.1093/ageing/afaa219
pubmed: 33068107
Nguyen QD, Wu C, Odden MC, Kim DH. Multimorbidity patterns, frailty, and survival in community-dwelling older adults. Journals Gerontology: Ser A. 2019;74(8):1265–70.
Vetrano DL, Palmer K, Marengoni A, Marzetti E, Lattanzio F, Roller-Wirnsberger R et al. Frailty and multimorbidity: a systematic review and meta-analysis. J Gerontol A Biol Sci. 2019 [cited 2020 May 4];74(5):659–66. http://www.ncbi.nlm.nih.gov/pubmed/29726918
Juul-Larsen HG, Christensen LD, Bandholm T, Andersen O, Kallemose T, Jørgensen LM, et al. Patterns of multimorbidity and differences in healthcare utilization and complexity among acutely hospitalized medical patients (≥ 65 years)– a latent class approach. Clin Epidemiol. 2020;12:245.
doi: 10.2147/CLEP.S226586
pubmed: 32184671
pmcid: 7053819
Abizanda P, Romero L, Sanchez-Jurado PM, Martinez-Reig M, Alfonso-Silguero SA, Rodriguez-Manas L. Age, frailty, disability, institutionalization, multimorbidity or comorbidity. Which are the main targets in older adults? Journal of Nutrition, Health and Aging. 2014 [cited 2023 Dec 20];18(6):622–7. https://link.springer.com/article/ https://doi.org/10.1007/s12603-014-0033-3
Abizanda P, Rodríguez-Mañas L. Function but not multimorbidity at the cornerstone of geriatric medicine. J Am Geriatr Soc. 2017 [cited 2023 Dec 20];65(10):2333–4. https://pubmed.ncbi.nlm.nih.gov/28832930/
Vetrano DL, Calderón-Larrañaga A, Marengoni A, Onder G, Bauer JM, Cesari M, et al. An international perspective on chronic multimorbidity: approaching the elephant in the room. Journals Gerontology: Ser A. 2018;73(10):1350–6.
Rosero-Bixby L, Fernández X, Dow WH. CRELES: Costa Rican longevity and healthy aging study, 2005 (Costa Rica Estudio de Longevidad y Envejecimiento Saludable). Inter-university Consortium for Political and Social Research [distributor]. NACDA: National Archive of Computerized Data on Aging; 2013 [cited 2023 Aug 24]. https://repository.synchros.eu/study/creles
Méndez Chacón E, Rosero Bixby L. Prevalencia De hipertensión en adultos mayores de Costa Rica. Poblac Salud Mesoam. 2007;5(1):1–9.
Brenes Camacho G, Rosero-Bixby L. Diabetes mellitus en adultos mayores costarricenses. Poblac Salud Mesoam. 2007;5(1).
Burki T. European commission classifies obesity as a chronic disease. Lancet Diabetes Endocrinol. 2021;9(7):418.
doi: 10.1016/S2213-8587(21)00145-5
pubmed: 34087168
Rosero-Bixby L, Dow WH, Brenes G. Costa Rican longevity and healthy aging study. Encyclopedia Gerontol Popul Aging. 2019:1–5.
Alden D, Austin C, Sturgeon R. A correlation between the geriatric depression scale long and short forms. J Gerontol. 1989;44(4):P124–5.
doi: 10.1093/geronj/44.4.P124
pubmed: 2738314
Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Biol Sci Med Sci. 2001;56(3):M146–57.
doi: 10.1093/gerona/56.3.M146
Rosero Bixby L, Dow WH, Brenes Camacho G. Costa Rican longevity and healthy aging study. 2019.
Gómez Melis G, Cadarso-Suárez C. El Modelo De Riesgos Proporcionales De Cox Y sus extensiones. Impacto en estadística y biomedicina - dialnet. Gaceta De La Real Sociedad Matemática Española. 2017;20(3):513–38.
Ng SK, Tawiah R, Sawyer M, Scuffham P. Patterns of multimorbid health conditions: a systematic review of analytical methods and comparison analysis. Int J Epidemiol. 2018;47(5):1687–704.
doi: 10.1093/ije/dyy134
pubmed: 30016472
Oude Voshaar RC, Jeuring HW, Borges MK, van den Brink RHS, Marijnissen RM, Hoogendijk EO et al. Course of frailty stratified by physical and mental multimorbidity patterns: a 5-year follow-up of 92,640 participants of the lifelines cohort study. BMC Med. 2021;19(1).
MacRae C, McMinn M, Mercer SW, Henderson D, McAllister DA, Ho I et al. The impact of varying the number and selection of conditions on estimated multimorbidity prevalence: a cross-sectional study using a large, primary care population dataset. PLoS Med. 2023 [cited 2024 Jan 17];20(4). https://pubmed.ncbi.nlm.nih.gov/37014910/
Wister AV, Multimorbidity Resilience. Conceptual, theoretical, and measurement developments. Resil Aging. 2020:81–105.
Rosero-Bixby L. The exceptionally high life expectancy of Costa Rican nonagenarians. Demography. 2008 [cited 2024 Jan 4];45(3):673. /pmc/articles/PMC2831395/
Rosero-Bixby L, Dow WH. Exploring why Costa Rica outperforms the United States in life expectancy: a tale of two inequality gradients. P Natl A Sci. 2016 [cited 2024 Jan 4];113(5):1130–7. https://www.pnas.org/doi/abs/ https://doi.org/10.1073/pnas.1521917112
Rosero-Bixby L, Dow WH. Surprising SES gradients in mortality, health, and biomarkers in a latin American population of adults. J Gerontol B Psychol Sci Soc Sci. 2009;64(1):105–17.
doi: 10.1093/geronb/gbn004
pubmed: 19196695
Basto-Abreu A, Barrientos-Gutierrez T, Wade AN, de Melo DO, de Souza ASS, Nunes BP et al. Multimorbidity matters in low and middle-income countries. https://doi.org/10.1177/26335565221106074 . 2022 [cited 2024 Jan 17];12:263355652211060. https://journals.sagepub.com/doi/full/ https://doi.org/10.1177/26335565221106074